Dr. Marten braced to report a sharp drop in profits and revenue as US sales plummet
Best foot forward: City analysts have predicted profits will fall by a third to £125m
Dr. Marten is prepared to report a sharp decline in profits and sales as sales in the US plummet.
The London-listed company’s turnover is expected to fall to £900m, down 11 per cent on last year, when it broke the £1bn mark for the first time.
City analysts have predicted profits will fall by a third to £125 million when the cult boot maker announces its annual results on Thursday.
Dr. Martens has suffered from declining revenues, with double-digit declines in the US in its April trading update.
The shoe brand has suffered an 80 percent drop in share price since its IPO three years ago.